Evidence map›Paper›PMID 41694248›Full record

ArticleF&S reports2026

Diagnostic odyssey of a male with 45,X/46,XY mosaicism: case report and review of the literature.

Stanislav Tjagur, Margus Punab, Avirup Dutta, Maris Laan

Abstract readCase Reports
In one paragraph

Article in F&S reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Stanislav TjagurAndrology Clinic, Tartu University Hospital, Tartu, Estonia.
Margus PunabAndrology Clinic, Tartu University Hospital, Tartu, Estonia.
Avirup DuttaChair of Human Genetics, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Maris LaanChair of Human Genetics, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To conduct longitudinal precision clinical phenotyping and management planning of 45,X/46,XY mosaicism case, including in-depth documentation of notable deviations at the male accessory glands level, monitoring and timely handling of potential comorbidities. Design: Case report. Subject: A 29-year-old phenotypically male patient of European origin presenting for andrological evaluation due to sudden enlargement of the right hemiscrotum. Results: We report a 29-year-old phenotypically male patient with 45,X/46,XY mosaicism and syndromic features, short stature (152 cm), inguinal hernia, azoospermia, moderate testicular hypotrophy (10 mL and 8 mL by orchidometer), distal hypospadias, and autoimmune thyroiditis. The patient presented normal intelligence quotient and cognition. As a novel clinical finding, notable deviations at the male accessory glands' level were documented in follow-up investigations, reduced prostate volume, unilateral hypoplasia of the seminal vesicle, absence of a distal deferential duct and a dilatation of the contralateral counterpart, dilatation of the ejaculatory duct and an extensive prostatic microcalcification. Intriguingly, an initial cytogenetic analysis from the peripheral blood leucocytes showed a normal male karyotype. Incidentally, 45,X/46,XY mosaicism was uncovered using whole exome sequencing (WES) of peripheral blood deoxyribonucleic acid for molecular diagnostic purposes. This genetic diagnosis was confirmed subsequently by interphase fluorescence in situ hybridization (buccal smear), chromosomal microarray analysis, and repeated cytogenetic testing of peripheral blood cells, emphasizing the sensitivity and precision of WES in detecting chromosomal mosaicism. The estimated proportion of 45,X cells ranged from 55% in buccal smear to 60%-67% in peripheral blood. Conclusion: Wolffian anomalies may be present in 45,X/46,XY phenotypic male mosaics and warrant systematic evaluation, particularly in the context of infertility management. This case also demonstrates that using WES instead of conventional karyotyping may enhance the speed in reaching 45,X/46,XY diagnosis, and consequently, longitudinal management of the broad spectrum of comorbidities in this condition.

Indexed as

45,X/46,XY mosaicismmale infertilityprostateshort staturewhole exome sequencing

Identifiers

PMID41694248
PMCPMC12905614

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.